Home > Insider Trading > Alder Biopharmaceuticals Inc

Alder Biopharmaceuticals Inc (ALDR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Did Hedge Funds Drop The Ball On On Alder Biopharmaceuticals Inc (ALDR) ?

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of June.

Keep Reading →

October 28th, 2019 - Hedge Funds News

Is Alder Biopharmaceuticals Inc (ALDR) A Good Stock To Buy ?

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...

Keep Reading →

June 29th, 2019 - Hedge Funds News

Here's What Hedge Funds Think About Alder Biopharmaceuticals Inc (ALDR)

With the fourth-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the first ...

Keep Reading →

May 7th, 2019 - Hedge Funds News

Is Alder Biopharmaceuticals Inc (ALDR) A Good Stock To Buy?

At Insider Monkey, we pore over the filings of more than 700 top investment firms every quarter, a process we have now completed for the latest reporting period.

Keep Reading →

December 19th, 2018 - Hedge Funds News

13D Filing: Redmile Group and Alder Biopharmaceuticals Inc (ALDR)

Alder Biopharmaceuticals Inc (NASDAQ:ALDR): Jeremy Green's Redmile Group filed an amended 13D. You can check out Redmile Group's latest holdings and filings here.

Keep Reading →

March 26th, 2018 - Hedge Funds

Is Alder Biopharmaceuticals Inc (ALDR) A Good Stock To Buy?

The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines.

Keep Reading →

December 7th, 2016 - Hedge Funds News

Cormorant Asset Management's Bets on Alder Biopharmaceuticals Inc (ALDR) and Other Healthcare Stocks Show Strong Returns

Bihua Chen's Cormorant Asset Management is one of some 750 investors that we track and whose quarterly 13F filings we analyze to identify stocks that they are collectively bullish on.

Keep Reading →

November 7th, 2016 - Hedge Funds News

Baker Bros. Opened Positions In These 5 Healthcare Stocks

Julian Baker and Felix Baker founded Baker Bros. Advisors in 2000.

Keep Reading →

October 16th, 2016 - Hedge Fund Analysis Hedge Funds News

Here’s What’s Important About Alder Biopharmaceuticals Inc (ALDR)’s Latest Release

Back in March, we discussed Alder Biopharmaceuticals Inc (NASDAQ:ALDR)’s lead migraine candidate ALD403.

Keep Reading →

July 27th, 2016 - News Stock Analysis

Alder Biopharmaceuticals Inc (ALDR) ALD403 Meets Trial Targets

Alder Biopharmaceuticals Inc (NASDAQ:ALDR) recently took the opportunity at the American Headache Society meeting in San Diego to present data from clinical trials of its compound ALD403.

Keep Reading →

June 10th, 2016 - News Stock Analysis